(Q34580951)

3 August 2017

1 reference

title

Insulin analogues: have they changed insulin treatment and improved glycaemic control? (English)

1 reference

3 August 2017

1 reference

Sten Madsbad

1

0 references

publication date

1 January 2002

1 reference

Diabetes - Metabolism: Research and Reviews

3 August 2017

published in

1 reference

3 August 2017

volume

18 Suppl 1

1 reference

3 August 2017

page(s)

S21-8

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

3 August 2017

cites work

1 reference

21 January 2018

Insulin Pharmacokinetics

1 reference

21 January 2018

1 reference

Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.

21 January 2018

1 reference

Insulin analogs with improved pharmacokinetic profiles

21 January 2018

1 reference

Monomeric insulins and their experimental and clinical implications

21 January 2018

1 reference

In vitro and in vivo potency of insulin analogues designed for clinical use.

21 January 2018

1 reference

Insulin analogues and their potential in the management of diabetes mellitus

21 January 2018

1 reference

Bioavailability and bioeffectiveness of subcutaneous human insulin and two of its analogs--LysB28ProB29-human insulin and AspB10LysB28ProB29-human insulin--assessed in a conscious pig model.

21 January 2018

1 reference

Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk

21 January 2018

1 reference

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

21 January 2018

1 reference

Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.

21 January 2018

1 reference

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

21 January 2018

1 reference

The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

21 January 2018

1 reference

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

21 January 2018

1 reference

Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control and hypoglycaemia

21 January 2018

1 reference

Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin.

21 January 2018

1 reference

Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal

21 January 2018

1 reference

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps

21 January 2018

1 reference

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

21 January 2018

1 reference

Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes

21 January 2018

1 reference

Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

21 January 2018

1 reference

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

21 January 2018

1 reference

The human insulin analogue insulin lispro

21 January 2018

1 reference

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

21 January 2018

1 reference

Monomeric insulins obtained by protein engineering and their medical implications

21 January 2018

1 reference

Time-action characteristics of regular and NPH insulin in insulin-treated diabetics

21 January 2018

1 reference

21 January 2018

1 reference

Equivalent in vivo biological activity of insulin analogues and human insulin despite different in vitro potencies

21 January 2018

1 reference

Action profile of the rapid acting insulin analogue: human insulin B28Asp

21 January 2018

1 reference

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

21 January 2018

1 reference

21 January 2018

1 reference

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group

21 January 2018

1 reference

Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM

21 January 2018

1 reference

Optimal time of administration of insulin lispro. Importance of meal composition

21 January 2018

1 reference

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

21 January 2018

1 reference

Optimal provision of daytime NPH insulin in patients using the insulin analog lispro

21 January 2018

1 reference

Improvement of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections

21 January 2018

1 reference

Evaluation of a structured outpatient group education program for intensive insulin therapy

21 January 2018

1 reference

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

21 January 2018

1 reference

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime

21 January 2018

1 reference

Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

21 January 2018

1 reference

Insulin lispro in CSII: results of a double-blind crossover study

21 January 2018

1 reference

21 January 2018

1 reference

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

21 January 2018

1 reference

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/DMRR.206

1 reference

3 August 2017

1 reference